COSA 2014* , ,
Presentations this author is a contributor to:
The new selective GLP-2 receptor agonist, Elsiglutide, improves irinotecan-induced diarrhoea and mucositis in the rat. (#224)
3:00 PM
Bronwen Mayo
Poster discussion 1
Apoptosis, proliferation and inflammation are improved after treatment with the new selective GLP-2 receptor agonist, Elsiglutide, in a rat model of irinotecan-induced mucositis. (#225)
3:00 PM
Bronwen Mayo
Poster discussion 1
Assessing the efficacy of ice-cream-formulated iron-saturated lactoferrin and anhydrous milk fat in preventing chemotherapy induced diarrhoea – the ReCharge Study, a randomised phase IIb trial (#127)
4:00 PM
Sarah Benge
Best of the Best Orals - Supportive care
Mucositis and its links to other toxicities in lung cancer (#83)
11:00 AM
Dorothy Keefe
Concurrent Session - Symptom management in lung cancer